Publications

Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

 62
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

Tags:

Previous Article

ERK1/2 signaling targeting in cancer

Next Article

MAPK inhibition to protect against spinal muscular atrophy

Related Posts

Body temperature regulates glucose metabolism and torpid behavior

Body temperature regulates glucose metabolism and torpi...

 76

The pro-oncogenic noncanonical activity of a RAS•GTP:RanGAP1 complex facilitates nuclear protein export

The pro-oncogenic noncanonical activity of a RAS•GTP:Ra...

 98

Cytokine-induced reprogramming of human macrophages toward Alzheimer’s disease-relevant molecular and cellular phenotypes in vitro

Cytokine-induced reprogramming of human macrophages tow...

 107